Publication:
SEOM clinical guidelines for anaplastic gliomas (2017).

Simple item page
dc.contributor.authorBalaña, C
dc.contributor.authorAlonso, M
dc.contributor.authorHernandez-Lain, A
dc.contributor.authorHernandez, A
dc.contributor.authorPerez-Segura, P
dc.contributor.authorPineda, E
dc.contributor.authorRamos, A
dc.contributor.authorSanchez, A R
dc.contributor.authorTeixidor, P
dc.contributor.authorVerger, E
dc.contributor.authorBenavides, M
dc.date.accessioned2023-01-25T10:01:04Z
dc.date.available2023-01-25T10:01:04Z
dc.date.issued2017-10-20
dc.description.abstractThe SEOM/GEINO clinical guidelines provide recommendations for radiological, and molecular diagnosis, treatment and follow-up of adult patients with anaplastic gliomas (AG). We followed the 2016 WHO classification which specifies the major diagnostic/prognostic and predictive value of IDH1/IDH2 missense mutations and 1p/19q codeletions in AG. The diagnosis of anaplastic oligoastrocytoma is discouraged. Surgery, radiotherapy and chemotherapy with PCV or TMZ are the first-line standard of care for AG with slight modifications according to molecular variables. A multidisciplinary team is highly recommended in the management of these tumors.
dc.description.versionSi
dc.identifier.citationBalañá C, Alonso M, Hernandez-Lain A, Hernandez A, Perez-Segura P, Pineda E, et al. SEOM clinical guidelines for anaplastic gliomas (2017). Clin Transl Oncol. 2018 Jan;20(1):16-21. doi: 10.1007/s12094-017-1762-7. Epub 2017 Oct 20. Erratum in: Clin Transl Oncol. 2018 Jul;20(7):937
dc.identifier.doi10.1007/s12094-017-1762-7
dc.identifier.essn1699-3055
dc.identifier.pmcPMC5785606
dc.identifier.pmid29058264
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785606/pdf
dc.identifier.unpaywallURLhttps://link.springer.com/content/pdf/10.1007/s12094-017-1762-7.pdf
dc.identifier.urihttp://hdl.handle.net/10668/11715
dc.issue.number1
dc.journal.titleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
dc.journal.titleabbreviationClin Transl Oncol
dc.language.isoen
dc.organizationHospital Universitario Virgen de la Victoria
dc.organizationHospital Universitario Regional de Málaga
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number16-21
dc.provenanceRealizada la curación de contenido 14/02/2025
dc.publisherSpringer
dc.pubmedtypeJournal Article
dc.pubmedtypePractice Guideline
dc.relation.publisherversionhttps://dx.doi.org/10.1007/s12094-017-1762-7
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectAnaplastic astrocytoma
dc.subjectAnaplastic glioma
dc.subjectAnaplastic oligodendroglioma
dc.subject.decsNeoplasias encefálicas
dc.subject.decsOligodendroglioma
dc.subject.decsHumanos
dc.subject.meshBrain Neoplasms
dc.subject.meshGlioma
dc.subject.meshHumans
dc.titleSEOM clinical guidelines for anaplastic gliomas (2017).
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number20
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
Thumbnail Image
Name:
PMC5785606.pdf
Size:
477.22 KB
Format:
Adobe Portable Document Format
Download
No Thumbnail Available
Name:
Balaña_SEOMClinical_Correcion.pdf
Size:
513.5 KB
Format:
Adobe Portable Document Format
Download

Collections

SAS - Hospital Universitario Virgen del Rocío
SAS - Hospital Regional Universitario de Málaga
SAS - Hospital Universitario Virgen de la Victoria

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía